About this trial
When admitted to the emergency department (ED), elderly non-autonomous patients show high risk of adverse health outcomes. The prompt identification of ED use risk factors in such population is hence needed. While cognitive impairment is a known clinical risk factor, biomarkers of most prevalent dementias have been scarcely investigated as possible ED use predictors. Within this context, this prospective study aims at exploring whether plasma phospho-tau181 and cerebrovascular burden can predict ED use at 6 months in elderly non-autonomous patients, irrespective of frailty.
Eligibility criteria
Qualifiers
fluency in Italian language,
age higher than 64 years,
loss of autonomies of daily living as assessed by the Katz Activities of Daily Living or in the Lawton Instrumental Activities of Daily Living questionnaires,
having performed routinary blood exams in the 6 months prior to recruitment
Disqualifiers
withdrawal of the informed consent
Trial design
Treatments tested in this trial
- Plasma phosphorylated Tau 181
Treatment groups
Sponsors and collaborators
University of Pisa
Lead sponsor
Azienda Ospedaliero, Universitaria Pisana
Collaborator